DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC)

Q: What does CUSIP 25253X207 represent in this 13F holders report?

CUSIP 25253X207 is the security identifier for DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value used to aggregate holder disclosures.

Q: How many institutions held DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value in Q1 2021?

38 institutional investors reported DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value for Q1 2021. Use the holders table for investor-level position and value details.

CUSIP: 25253X207

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Voting Common Shares, no par value
Shares outstanding: 52,272,727
Total 13F shares: 5,694,347
Share change: -289,912
Total reported value: $88,119,211
Price per share: $9.15
Number of holders: 38
Value change: +$33,217,401
Number of buys: 22
Number of sells: 13

Quarterly Holders Quick Answers

What is CUSIP 25253X207?
CUSIP 25253X207 identifies DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 25253X207:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Stonepine Capital Management, LLC	13F	Company	1.8%	950,000	$9,633,000	—	31 Dec 2020	13F
Corriente Advisors, LLC	13F	Company	1.5%	806,900	$8,182,000	—	31 Dec 2020	13F
Point72 Asset Management, L.P.	13F	Company	1.5%	800,000	$8,112,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	1.5%	779,898	$7,908,000	—	31 Dec 2020	13F
Manatuck Hill Partners, LLC	13F	Company	1.1%	571,500	$5,795,000	—	31 Dec 2020	13F
Granite Point Capital Management, L.P.	13F	Company	1%	546,855	$5,545,000	—	31 Dec 2020	13F
Ikarian Capital, LLC	13F	Company	0.79%	415,000	$4,208,000	—	31 Dec 2020	13F
JACOB ASSET MANAGEMENT OF NEW YORK LLC	13F	Company	0.27%	140,000	$1,420,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	0.23%	120,989	$1,227,000	—	31 Dec 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.22%	113,400	$1,150,000	—	31 Dec 2020	13F
Informed Momentum Co LLC	13F	Company	0.21%	109,985	$1,115,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.2%	103,699	$1,051,000	—	31 Dec 2020	13F
BANK OF MONTREAL /CAN/	13F	Company	0.16%	81,882	$764,000	—	31 Dec 2020	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.13%	66,250	$671,000	—	31 Dec 2020	13F
MARSHALL WACE, LLP	13F	Company	0.11%	59,871	$607,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	0.11%	55,781	$566,000	—	31 Dec 2020	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.09%	46,562	$472,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	0.08%	42,905	$435,000	—	31 Dec 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.08%	40,861	$414,000	—	31 Dec 2020	13F
Leon G. Cooperman	13F	Individual	0.06%	30,000	$304,000	—	31 Dec 2020	13F
MORGAN STANLEY	13F	Company	0.04%	20,660	$210,000	—	31 Dec 2020	13F
Qube Research & Technologies Ltd	13F	Company	0.04%	18,785	$190,000	—	31 Dec 2020	13F
Virtu Financial LLC	13F	Company	0.03%	15,712	$159,000	—	31 Dec 2020	13F
ExodusPoint Capital Management, LP	13F	Company	0.03%	13,160	$133,000	—	31 Dec 2020	13F
JANE STREET GROUP, LLC	13F	Company	0.02%	12,537	$127,000	—	31 Dec 2020	13F
Federation Des Caisses Desjardins du Quebec	13F	Individual	0.01%	6,030	$61,144	—	31 Dec 2020	13F
Valeo Financial Advisors, LLC	13F	Company	0.01%	5,000	$51,000	—	31 Dec 2020	13F
US BANCORP \DE\	13F	Company	0.01%	4,335	$44,000	—	31 Dec 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	2,106	$21,000	—	31 Dec 2020	13F
UBS Group AG	13F	Company	0%	914	$9,000	—	31 Dec 2020	13F
ROYAL BANK OF CANADA	13F	Company	0%	805	$8,000	—	31 Dec 2020	13F
Credential Qtrade Securities Inc.	13F	Company	0%	769	$7,797	—	31 Dec 2020	13F
GABLES CAPITAL MANAGEMENT INC.	13F	Company	0%	542	$5,000	—	31 Dec 2020	13F
Newbridge Financial Services Group, Inc.	13F	Company	0%	427	$4,000	—	31 Dec 2020	13F
FEDERATED HERMES, INC.	13F	Company	0%	68	$1,000	—	31 Dec 2020	13F

Institutional Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q1 2021

As of 31 Mar 2021, DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) was held by 38 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,694,347 shares. The largest 10 holders included Stonepine Capital Management, LLC, Corriente Advisors, LLC, VANGUARD GROUP INC, Manatuck Hill Partners, LLC, Point72 Asset Management, L.P., Ikarian Capital, LLC, JACOB ASSET MANAGEMENT OF NEW YORK LLC, Granite Point Capital Management, L.P., RENAISSANCE TECHNOLOGIES LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 38 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

Q1 2021 holders

Holder diff

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.